Sort
89,613 grants matching “depression”
NAAA Inhibition for Pain and Inflammation
$983,494Edward Paul Monaghan · Neokera, Llc · R44 · FY2018 · NS
Indiana PREGMED
$983,372David Alastair Flockhart · Indiana University Indianapolis · U10 · FY2010 · HD
Preclinical Alzheimer Disease and Driving
$983,337Catherine M Roe · Washington University · R01 · FY2017 · AG
Parent Engagement and Child Learning Birth to Five
$983,321Susan M Sheridan · University Of Nebraska Lincoln · R01 · FY2007 · HD
Stream Dx: Point of Care Cellular Enabled IoT Communication Hub for Improved Diagnosis, Monitoring, and Post-Treatment Evaluation of LUTS
$983,074Scott Bradford McClellan · Stream Dx, Inc. · R44 · FY2021 · DK
Operations, Clinical Assessments and Adminstrative Core
$983,062Helen S Mayberg · Emory University · P50 · FY2009 · MH
Phosphodiesterase-4B (PDE4B) Inhibitors for Psychiatric Disease
$982,403Mark E Gurney · Tetra Discovery Partners, Inc. · R44 · FY2018 · MH
CLINICAL EPIDEMIOLOGY OF DEMENTIA IN GENERAL PRACTICE
$982,402University Of Pittsburgh At Pittsburgh · R01 · FY2003 · AG
Developing Infrastructure for Patient-Centered Outcomes Research at Denver Health
$982,012Edward Havranek · Denver Health And Hospital Authority · R24 · FY2017 · HS
Developing novel technologies to monitor nociception and opioid administration during surgery and general anesthesia in order to minimize post-operative opioid requirements
$981,839Tuan Le Mau · Pascall Systems, Incorporated · R42 · FY2023 · DA
Leveraging Protein Kinase G-1 Nanodomain Control and Molecular Targeting to Enhance its Therapeutic Use Against Myocardial Disease
$981,748David Alan Kass · Johns Hopkins University · R35 · FY2021 · HL
Leveraging Protein Kinase G-1 Nanodomain Control and Molecular Targeting to Enhance its Therapeutic Use Against Myocardial Disease
$981,748David Alan Kass · Johns Hopkins University · R35 · FY2022 · HL
Leveraging Protein Kinase G-1 Nanodomain Control and Molecular Targeting to Enhance its Therapeutic Use Against Myocardial Disease
$981,748David Alan Kass · Johns Hopkins University · R35 · FY2019 · HL
Leveraging Protein Kinase G-1 Nanodomain Control and Molecular Targeting to Enhance its Therapeutic Use Against Myocardial Disease
$981,748David Alan Kass · Johns Hopkins University · R35 · FY2020 · HL
Aligning facility leadership and climate to advance mental health services integration in Malawi
$981,668Brian W Pence · Univ Of North Carolina Chapel Hill · R01 · FY2023 · MH
Digital multidomain lifestyle intervention to address cognitive health and modifiable risk factors for Alzheimer's disease
$981,630Jordan Glenn · Neurotrack Technologies, Inc. · R44 · FY2022 · AG
Neuropeptides and Carboxypeptidase E/ Neurotrophic Factor-1 in Neural and Cognitive Functions
$981,601Yoke Peng Loh · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2018 · HD
CBASP Augmentation for Treatment of Chronic Depression
$981,549University Of Pittsburgh At Pittsburgh · U01 · FY2004 · MH
Leveraging Protein Kinase G-1 Nanodomain Control and Molecular Targeting to Enhance its Therapeutic Use Against Myocardial Disease
$981,073David Alan Kass · Johns Hopkins University · R35 · FY2018 · HL
Mindfulness-based Cognitive Coping Mobile App Intervention for caregivers of individuals with Alzheimer's Disease
$980,975Bruno Kajiyama · Photozig, Inc. · R44 · FY2021 · AG
NCMHD-Research Center of Excellence at the University of Pittsburgh
$980,936Stephen B. Thomas · University Of Pittsburgh At Pittsburgh · P60 · FY2008 · MD
The Proactive Screening and diagnosis of mild cognitive impairment and depression in patients aged 65 and over: An Implementation Study
$980,904Shenly Glenn · Miro Health Inc · R44 · FY2023 · AG
Pre-Operative PSG Assessment of Cardiac Surgery Inpatients
$980,873Hani Akram Kayyali · Cleveland Medical Devices, Inc. · R44 · FY2006 · NS
Enhanced supercooling for extending non-freezing preservation in preclinical porcine and human donor livers
$980,782Michael John Taylor · Sylvatica Biotech, Inc. · R44 · FY2025 · DK
Efficacy of CBT for Adherence and Depression in HIV Care Settings
$980,660Steven A Safren · Massachusetts General Hospital · R01 · FY2011 · MH